American Chemical Society: Multiple Sclerosis Drug Shows Promise to Counteract Effects of Botulinum Neurotoxin

News-Medical -- Scientists are reporting that variants of a drug already approved for treating multiple sclerosis show promise as a long sought treatment for victims of bioterrorist attack with botulinum neurotoxin - which is 10,000 times deadlier than cyanide and the most poisonous substance known to man. The potential drugs also could be useful in treating other forms of botulism poisoning as well as Alzheimer’s disease, multiple sclerosis, and myasthenia gravis, they say in an article in ACS Chemical Biology, a monthly journal.

MORE ON THIS TOPIC